LSHTM Research Online

Bracken, H; Gliozheni, O; Kati, K; Manoku, N; Moisiu, R; Shannon, C; Tare, V; Tasha, I; Winikoff, B; Medical Abortion Research Group, ; (2006) Mifepristone medical abortion in Albania: results from a pilot clinical research study. The European journal of contraception & reproductive health care, 11 (1). pp. 38-46. ISSN 1362-5187 DOI: https://doi.org/10.1080/13625180500361058

Full text not available from this repository.

Abstract

OBJECTIVE: To explore the acceptability and feasibility of introducing mifepristone-misoprostol for early medical abortion in home and clinic settings in Albania. METHODS: This was a prospective study testing a simplified mifepristone-misoprostol regimen in two tertiary-level government health facilities in Tirana, Albania. Women (n = 409) with amenorrhea of 8 weeks or less received 200 mg mifepristone in the clinic and then chose whether to take 400 microg of oral misoprostol 2 days later either at home or in the clinic. RESULTS: Nearly 97% of women successfully terminated their pregnancies using the simplified regimen. Almost all women found the method either satisfactory (49.4%) or highly satisfactory (41.1%). Almost all women who were given the option selected the home use protocol. Women choosing home administration of misoprostol were able to manage the medical abortion process on their own. CONCLUSION: A reduced dose mifepristone medical abortion regimen with home administration of misoprostol is feasible for introduction into healthcare facilities in Albania.

Item Type:	Article
Faculty and Department:	Faculty of Epidemiology and Population Health > Dept of Population Health (2012- )
PubMed ID:	16546815
Web of Science ID:	236994100006
URI:	http://researchonline.lshtm.ac.uk/id/eprint/2103

Actions (login required)

Edit Item